Chief Financial Officer leaves Vigmed

Vigmed announces today that Donya Gholamifar, Chief Financial Officer of Vigmed, has decided to leave the company for an employment outside of the Medtech industry. Donya will remain as CFO and member of the Management Team until she leaves the position in the end of August 2017.

“It is very unfortunate that Donya has decided to leave Vigmed as she holds deep knowledge of the company and is a respected and trusted colleague to us”, says Henrik Olsen, CEO. “I was looking forward to work together with Donya but I fully respect her decision to leave Vigmed and wish her all the best in the future.”

The process to recruit a replacement will commence shortly.

For further information contact:
CEO Henrik Olsen, +46 763-497 364

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries and the associated risk of cross infections with blood-borne infectious diseases by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG). Remium Nordic AB is the Company’s Certified Advisor.Additional information about the company can be found on Vigmed’s website:   www.vigmed.com/investor  

Tags:

About Us

Vigmed is a Swedish medical technology company whose mission is to eliminate needlestick injuries by offering the market unique needle-protected products. Vigmed is headquartered in Helsingborg, Sweden. Vigmed’s share is traded on NASDAQ OMX First North in Stockholm (ticker VIG) and the company has approximately 5 600 shareholders. Remium Nordic AB is the Company’s Certified Advisor. Additional information can be found on Vigmed’s home page: www.vigmed.com

Subscribe

Documents & Links